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Aims Our objective was to investigate whether pro-oxidant properties of ascorbic acid (AA) and tetra-
hydrobiopterin (BH4) modulate endothelium-dependent, electrotonically mediated arterial relaxation.
Methods and results In studies with rabbit iliac artery (RIA) rings, NO-independent, endothelium-
derived hyperpolarizing factor (EDHF)-type relaxations evoked by the sarcoplasmic endoplasmic reticu-
lum Ca
2þ-ATPase inhibitor cyclopiazonic acid and the G protein-coupled agonist acetylcholine (ACh)
were enhanced by AA (1 mM) and BH4 (200 mM), which generated buffer concentrations of H2O2 in
the range of 40–80 mM. Exogenous H2O2 potentiated cyclopiazonic acid (CPA)- and ACh-evoked relax-
ations with a threshold of 10–30 mM, and potentiation by AA and BH4 was abolished by catalase,
which destroyed H2O2 generated by oxidation of these agents in the organ chamber. Adventitial appli-
cation of H2O2 also enhanced EDHF-type dilator responses evoked by CPA and ACh in RIA segments per-
fused intraluminally with H2O2-free buffer, albeit with reduced efﬁcacy. In RIA rings, both control
relaxations and their potentiation by H2O2 were overcome by blockade of gap junctions by connexin-
mimetic peptides (YDKSFPISHVR and SRPTEK) targeted to the ﬁrst and second extracellular loops of
the dominant vascular connexins expressed in the RIA. Superoxide dismutase attenuated the poten-
tiation of EDHF-type relaxations by BH4, but not AA, consistent with ﬁndings demonstrating a differen-
tial role for superoxide anions in the generation of H2O2 by the two agents.
Conclusion Pro-oxidant effects of AA and BH4 can enhance the EDHF phenomenon by generating H2O2,
which has previously been shown to amplify electrotonic hyperpolarization-mediated relaxation by
facilitating Ca






In many arteries, NO-independent relaxations can be inhib-
ited by synthetic connexin-mimetic peptides that interrupt
intercellular communication via myoendothelial and homo-
cellular smooth muscle gap junctions, suggesting that such
responses are electrotonic in nature, rather than mediated
by a freely diffusible endothelium-derived hyperpolarizing
factor (EDHF).
1–3 We have previously provided evidence
that H2O2 can potentiate such ‘EDHF-type’ relaxations in
rings of rabbit iliac artery (RIA) when these are evoked by
cyclopiazonic acid (CPA), an agent that promotes
store-operated endothelial Ca
2þ entry by inhibiting the sar-




4 This novel action of H2O2 may reﬂect
enhanced Ca
2þ store depletion secondary to sensitization
of the InsP3 receptor, with the resulting increase in Ca
2þ
mobilization promoting the opening of the hyperpolarizing
endothelial KCa channels that are widely recognized to
underpin the EDHF phenomenon.
4–6 We have also shown
that the inhibitory effects of connexin-mimetic peptides
against EDHF-type relaxations are attenuated by ascorbic
acid (AA) and R-5,6,7,8-tetrahydrobiopterin (BH4),
7,8
whose ability to improve endothelial function in patients
with hypertension, hypercholesterolaemia, diabetes, and
heart failure has widely been attributed to their ability to
prevent uncoupling of the constitutive eNOS and thereby
reduce production of the superoxide anion (.O2
2) by the
oxygenase component of the enzyme.
9–13 It is well known,
however, that AA and BH4 can generate H2O2 following
oxidation by molecular oxygen in aqueous solution.
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Cardiovascular Research (2009) 84, 218–226
doi:10.1093/cvr/cvp235To examine whether this pro-oxidant activity also modulates
endothelium-dependent relaxation, we have correlated the
ability of AA and BH4 to generate H2O2 with potentiation of
EDHF-type relaxations evoked by CPA and acetylcholine
(ACh) in the RIA. In this vessel, H2O2 cannot be regarded
as an EDHF because H2O2-evoked changes in smooth
muscle membrane potential are much smaller than those
associated with endothelium-dependent smooth muscle
hyperpolarization, and H2O2-evoked relaxations of
endothelium-denuded preparations are unaffected by block-
ade of K
þ channels.
4,16 Most experiments were conducted
with ring preparations in which the endothelium was
directly exposed to H2O2, but H2O2 was also applied adven-
titially in perfused arterial segments to mimic the in vivo
situation where systemic administration of pharmacological
doses of AA have been shown to generate high concen-
trations of H2O2 in interstitial ﬂuid, but circulating H2O2 is




Experiments were performed with iliac arteries from male NZW
rabbits (2–2.5 kg) sacriﬁced by injection of sodium pentobarbitone
(120 mg/kg i.v.). Protocols conformed to UK Home Ofﬁce regulations
and the Guide for the Care and Use of Laboratory Animals issued by
the US National Institutes of Health (NIH Publication No. 85–23,
revised 1996). Tissues were transferred to oxygenated (95% O2,5 %
CO2) Holman’s buffer containing (in mM): NaCl 120, KCl 5,
NaH2PO4 1.3, NaHCO3 25, CaCl2 2.5, glucose 11, and sucrose 10.
Myograph experiments were conducted with oxygenated Holman’s
solution (95% O2,5 %C O 2)a t3 7 8C and pH 7.4. To evaluate EDHF-type
responses, in all experiments, the cyclooxygenase inhibitor indo-
methacin (10 mM) and N
G-nitro-L-arginine methyl ester (300 mM)
were added to the buffer 40 min before tone was induced by phenyl-
ephrine (PE, 1 mM). All pharmacological agents were obtained from
Sigma, UK.
2.1 Tension myography
Rings (2–3 mm wide) were mounted in a myograph (model 610M;
Danish MyoTechnology, Aarhus) placed under a resting tension of
1 mN and then allowed to equilibrate for 30 min with readjust-
ments of tension to compensate for stress relaxation. Cumulative
concentration–response curves to CPA and ACh were constructed
under control conditions and after 30 min incubation with AA
(1 mM) or BH4 (200 mM) in the presence and absence of catalase
(Cat No. C9322 derived from bovine liver) or superoxide dismutase
(SOD) (Cat No. S7571 derived from bovine erythrocytes). Some
rings were incubated with H2O2 (10, 30, or 100 mM) for 30 min
before constriction. The role of gap junctions was investigated by
pre-incubating for 20 min with
43Gap26 (VCYDKSFPISHVR; 100 mM),
the truncated peptide YDKSFPISHVR, and the short peptides
SRPTEK or its unnatural enantiomeric D-isomer srptek (each at
300 mM). Stock solutions were prepared in buffer with the exception
of CPA (DMSO), indomethacin (5% ethanol),
43Gap 26 and YDKSF-
PISHVR (dH2O) and SRPTEK/srptek (10% acetic acid). Peptides
were conﬁrmed to be of greater than 85% purity by HPLC.
2.2 Perfusion myography
Iliac artery segments (4–5 mm in length) were cannulated onto two
glass micropipettes in a pressure myograph (Living Systems Instru-
mentation, USA). Flow and pressure were ﬁxed at 0.5 mL/min and
75 mmHg, respectively, giving a basal external arterial diameter
1500 mm. PE (1 mM), CPA and ACh were administered intralumin-
ally and in some experiments 100 mMH 2O2 was added to the
extraluminal Holman’s solution in the myograph chamber 30 min
before constriction. At the end of each experiment, arteries were
perfused with sodium nitroprusside (SNP, 100 mM) to induce full dila-
tation. Diameter changes were recorded on PowerLab 400 using
Chart v4.1.2 software (AD Instruments, UK).
2.3 Hydrogen peroxide assay
Brieﬂy, 300 mL samples of buffer were collected at the beginning
and end of relaxation protocols in experiments with ACh or CPA (cor-
responding to AA/BH4 incubation times of 30 and 60 min). These
were added to Amplex Red (10 mM) and horseradish peroxidase
(0.6 U/mL) in a 96-well plate and incubated in the dark at room
temperature for 15 min. Absorbance was read at 560 nm using a
Fluostar optima spectrophotometer (BMG Labtech) and H2O2 con-
centrations derived from a standard curve. Experiments were also
performed in the absence of arterial rings with buffer maintained
at 378C and either oxygenated with 95% O2/5% CO2 or exposed to
air. In perfusion experiments, buffer was sampled from the myo-
graph chamber and the efﬂuent from the artery under study.
2.4 Mass spectra
Peptide mass spectra were recorded using either a Waters 1525 m
HPLC or UPLC Aquity autosamplers equipped with LCT Premier XE
or Q-Tof micro mass sensitive detectors, respectively. Spectra
were obtained in electrospray positive ion mode (ESI
þ) using a
carrier solvent of 50:50 mixture of acetonitrile:deionized water.
Formic acid (0.1% of eluent) was used as the proton source.
2.5 Statistics
In tension experiments, the maximal percentage reversal of
PE-induced constriction (Rmax) by CPA or ACh and concentrations
giving 50% reversal of this constrictor response (IC50 for CPA) or
50% of maximal relaxation (EC50 for ACh) were determined for
each experiment. The use of IC50 rather than EC50 values was
necessary to allow for a small initial CPA-induced constriction
observed in ring experiments.
4,8 In perfusion studies, dilatations
evoked by CPA and ACh were expressed as a function of the response
to SNP, to calculate EC50 and Dmax. All parameters were calculated
as mean+SEM and compared by the Student’s t-test or ANOVA fol-
lowed by a Bonferroni post-test. P , 0.05 was considered signiﬁ-
cant; n denotes the number of animals studied or assays
performed for each data point.
3. Results
3.1 Effects of AA and BH4 on CPA- and ACh-evoked
relaxation
Pre-incubation of RIA rings with 1 mM AA or 200 mMB H 4
caused leftward shifts in the concentration–relaxation
curves for CPA and ACh without affecting Rmax and increased
buffer [H2O2]t o40 and 60 mM after 60 min, respectively
(Figure 1A–D and Table 1). Increases in myograph [H2O2] and
the potentiating effects of AA and BH4 on relaxation were
abolished by 1000 U/mL catalase, which did not itself modu-
late control responses to either CPA or ACh (Figure 1A–D and
Table 1).
3.2 Effects of H2O2 on CPA- and ACh-evoked
relaxation/dilatation
Pre-incubation of endothelium-intact rings with increasing
[H2O2] progressively lowered IC50/EC50 values for CPA and
ACh with a threshold for potentiation between 10 and
30 mMH 2O2, but exerted no effect on Rmax even at 100 mM
Ascorbate, tetrahydrobiopterin, and EDHF 219H2O2 (Figure 2A; Table 1). Assay of buffer on completion of
the relaxation protocols conﬁrmed that intrinsic antioxidant
mechanisms did not reduce applied myograph [H2O2]
(Figure 2A). In perfused RIA segments, concentrations of
CPA and ACh causing 50% of maximal dilatation were
similar to the IC50/EC50 values observed in rings, and adven-
titial application of 100 mMH 2O2 potentiated these
responses to an extent intermediate between 30 and
100 mMH 2O2 in rings, again without affecting Dmax
(Figure 2B; Tables 1 and 2). H2O2 was undetectable in
buffer exiting from the lumen of segments exposed to
100 mMH 2O2 on their adventitial surface (Figure 2B).
3.3 Role of superoxide anions
SOD (1200 U/mL) did not affect the potentiation of
CPA-evoked relaxation caused by 1 mM AA, but signiﬁcantly
attenuated the potentiation observed with 200 mMB H 4
(Figures 3A and 4A; Table 1). Corresponding assays of myo-
graph [H2O2] demonstrated that generation of H2O2 from
AA was unaffected by SOD at 30 or 60 min (i.e. the start
and completion of the relaxation protocols), whereas H2O2
accumulation from BH4 was reduced by 50% after 30 min,
but unaffected at 60 min (Figures 3A and 4A).
In experiments conducted in well-oxygenated buffer (95%
O2/5% CO2) in the absence of arterial rings, generation of
H2O2 from 1 mM AA rose to a plateau at 60–90 min
(Figure 3B). The transition metal chelator DTPA caused a
concentration-dependent reduction in H2O2 accumulation
at 30 min, and no H2O2 was detectable in experiments
employing oxygenated deionized water rather than buffer
(Figure 3C). Generation of H2O2 from 1 mM AA was
insensitive to the presence of SOD and was two- to three-
fold greater in well-oxygenated buffer compared with
buffer exposed to air (Figure 3D).
In analogous experiments with 200 mMB H 4, generation of
H2O2 was rapid (60 mM after 5 min) and rose to a peak at
90 mM at 30 min before subsequently declining at 60 and
90 min (Figure 4B), but was unaffected by DTPA, in contrast
to AA (Figure 4C). The high concentrations of DTPA required
to inhibit the accumulation of H2O2 in experiments with AA
are likely to reﬂect competition between Ca
2þ and other
metal ions present in the buffer (see Supplementary
material online).
Accumulation of H2O2 after 30 min was similar at 80 mM
whether the buffer was well-oxygenated or exposed to air,
but in buffer exposed to air accumulation of H2O2 was
almost abolished by SOD at concentrations  300 U/mL
after 30 min, whereas in well-oxygenated buffer H2O2 pro-
duction was depressed only at SOD concentrations
 900 U/mL, with 1200 U/mL SOD causing an overall
reduction of 50% (Figure 4D).
3.4 Role of gap junctions
Pre-incubation of RIA rings with 100 mM
43Gap26 attenuated
relaxations to CPA, reducing Rmax to 30%, as previously
reported.
3,7,8 Potentiation of CPA-evoked relaxation by
100 mMH 2O2 was lost in the presence of this peptide,
which normalized relaxation (Figure 5A). Electrospray
mass spectrometry demonstrated that samples of
43Gap26
treated with H2O2 (both at 100 mM) at pH 7 that were
allowed to stand for 60 min either in buffer or deionized
water displayed substantial oxidation to cystine-bridged
Figure 1 Effects of AA and BH4 on EDHF-type relaxations to CPA and ACh in RIA rings. (A and B) 1 mM AA and (C and D) 200 mMB H 4 each elevated bath [H2O2] (bar
graphs) and resulted in a catalase-sensitive potentiation of relaxation. [H2O2] was measured at the conclusion of each experiment, i.e. after 60 min incubation
with AA or BH4. ***P , 0.001 for speciﬁc concentrations of CPA or ACh compared with control.
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nated species [(VCYDKSFPISHVR)2 - 2H]þ3H
þ (calculated
m/e for C140H212N38O38S2þ 3H
þ {Mþ3H
þ} 1033.52; found
1033.46), the triple sodium adduct [(VCYDKSFPISHVR)2 -
2H]þ3Na
þ (calculated m/e for C140H212N38O38S2þ3Na
þ
{Mþ3Na
þ} 1055.50; found 1055.80), and mixed proton/
sodium adducts at intermediate mass values.
Pre-incubation with a cysteine-free truncated form of
43Gap26 (YDKSFPISHVR at 300 mM) closely mimicked the
effects of
43Gap26 at 100 mM( Figure 5A). Pre-incubation
with the short peptide SRPTEK at 300 mM markedly attenu-
ated relaxations to ACh, reducing Rmax to less than 30%,
whereas the corresponding D-isomer srptek was inactive;
SRPTEK similarly abolished the potentiated ACh-evoked
relaxations observed in the presence of 100 mMH 2O2
(Figure 5B). Mass spectrometry conﬁrmed the lack of dimer-
ization of the YDKSFPISHVR or SRPTEK oligopeptides (data
not shown).
Direct chemical interaction between
43Gap26 and H2O2
was conﬁrmed by the demonstration that there was 50%
consumption of 100 mMH 2O2 30 min after addition to air-
exposed Holman’s buffer containing 100 mM
43Gap26,
whereas consumption of H2O2 was not evident in buffer con-
taining 100 mM SRPTEK (Figure 5C).
4. Discussion
The major ﬁnding of the present study is that AA and BH4
potentiate EDHF-type relaxations of rabbit arteries evoked
by CPA and ACh through a mechanism that is sensitive to
catalase. Control and potentiated responses were both
inhibited by connexin-mimetic peptides. It follows that
H2O2 generated by the oxidation of AA and BH4 can
amplify NO-independent arterial relaxations mediated by
the spread of endothelial hyperpolarization via gap
junctions.
Incubation of RIA rings with 1 mM AA or 200 mMB H 4
enhanced EDHF-type responses with the threshold for relax-
ation decreasing from 10–30 mMt o1 mM with CPA and
from 0.1 mMt o0.01 mM with ACh. Assay of myograph
[H2O2] after 60 min incubation revealed conversion rates
of 4% and 30% for AA and BH4, respectively, consistent
with evidence that BH4 is more readily oxidized by molecular
oxygen than AA in physiological buffer.
13 The potentiating
effects of AA and BH4, but not control responses, were inhib-
ited by catalase and could be mimicked by exogenous H2O2,
which itself enhanced EDHF-type relaxations at a threshold
concentration of 10–30 mM. The observation that H2O2
ampliﬁes relaxant responses to ACh, which mobilizes Ca
2þ
Table 1 Effects of pharmacological interventions on EDHF-type relaxations evoked by CPA and ACh by in the presence and absence of H2O2
or catalase
CPA n pIC50 Rmax% ACh n pEC50 Rmax%
Control 5 4.61+0.01 92.8+2.1 Control 5 6.55+0.09 75.8+2.7
Catalase 5 4.66+0.07 93.8+2.4 Catalase 5 6.64+0.08 77.2+3.3
AA 5 5.12+0.05*** 92.3+2.3 AA 5 7.00+0.06* 81.9+1.2
AAþcatalase 5 4.59+0.11 91.5+3.0 AAþcatalase 5 6.48+0.10 75.3+2.2
Control 7 4.70+0.10 79.6+5.4 Control 6 6.43+0.08 76.6+3.8
Catalase 7 4.74+0.04 85.8+2.5 Catalase 6 6.39+0.10 73.1+3.6
BH4 7 5.39+0.15*** 85.1+2.1 BH4 6 6.91+0.04** 79.7+3.1
BH4þcatalase 7 4.76+0.05 83.9+2.5 BH4þcatalase 6 6.42+0.08 71.2+3.9
Control 7 4.64+0.04 84.3+3.1 Control 8 6.50+0.06 74.9+4.4
H2O2 (10mM) 7 4.80+0.04 90.3+1.6 H2O2 (10 mM) 7 6.55+0.08 72.7+5.2
H2O2 (30 mM) 7 4.96+0.10 91.6+2.5 H2O2 (30 mM) 6 6.87+0.20 76.8+5.5
H2O2 (100 mM) 7 5.36+0.17*** 86.0+2.5 H2O2 (100 mM) 9 7.25+0.15*** 74.7+4.1
Control 4 4.80+0.03 92.6+1.4 Control 7 6.46+0.09 69.0+3.0
SOD (1200 U) 4 4.71+0.04 84.1+2.0 SRPETK 7 — 26.5+7.3***
AA 4 5.53+0.19** 87.5+3.6 srptek 5 6.29+0.24 68.9+5.6
AAþSOD 4 5.53+0.15** 90.2+2.0
Control 4 4.67+0.16 93.4+3.2 Control 7 6.63+0.10 77.9+5.4
SOD (1200 U) 4 4.66+0.06 80.0+7.9 SRPTEK 7 — 34.2+8.9**
BH4 4 6.01+0.20*** 88.1+7.1 SRPTEKþH2O2 5 — 39.0+11.1*
BH4þSOD 4 5.39+0.21* 85.5+9.1 H2O2 (100 mM) 5 7.16+0.1** 74.6+7.1
Control 6 4.92+0.11 78.0+7.6
43Gap26 (100 mM) 6 - 30.6+6.9**
43Gap26þH2O2 4 5.03+0.17 73.5+10.4
H2O2 (100 mM) 4 6.31+0.15*** 72.8+7.9
Control 6 4.73+0.05 83.1+3.8
YDKSFPISHVR (300 mM) 4 - 35.2+14.1***
YDKSFPISHVRþH2O2 4 4.59+0.01 80.2+3.3
H2O2 (100 mM) 6 5.30+0.11*** 84.3+4.2
Potency (negative log IC50 or EC50) and maximal relaxation (Rmax) expressed as a percentage of the constrictor response to phenylephrine are given as
mean+SEM.
*P , 0.05 compared with control.
**P , 0.01 compared with control.
***P , 0.001 compared with control.
Ascorbate, tetrahydrobiopterin, and EDHF 221from the ER store via the formation of InsP3, is consistent
with evidence that H2O2 enhances Ca
2þ release by sensitiz-
ing the InsP3 receptor and extends previous ﬁndings with
CPA which elevates endothelial [Ca
2þ]i by blocking ER Ca
2þ
uptake.
4–6 EDHF-type relaxations evoked by CPA and ACh
can also be potentiated by the sulphydryl reagent thimero-
sal, which ampliﬁes Ca
2þ release from the ER by oxidizing
critical thiol groups present in the InsP3 receptor, thus
raising the possibility of a molecular target common to
H2O2 and thimerosal.
4,19–21 It should be appreciated that
the concentrations of buffer H2O2 generated from AA and
BH4 in the present study are likely to correspond to intra-
cellular levels within the suggested physiological range
(1–10 mM), since glutathione peroxidase, catalase, and
other mechanisms are thought to limit cytosolic [H2O2]t o
1–15% of that applied extracellularly.
22
In the rat, microdialysis techniques have shown that sys-
temic administration of AA at pharmacological doses sufﬁ-
cient to achieve circulating AA levels of 1–10 mM causes
extravascular accumulation of H2O2 and the ascorbyl
radical (a marker of AA oxidation) at concentrations that
correlate directly with plasma [AA], with interstitial ﬂuid
[H2O2] rising to 20–150 mM but H2O2 remaining undetectable
in the intravascular compartment.
17,18 To mimic this in vivo
situation, 100 mMH 2O2 was selectively applied to the adven-
titia of perfused RIA segments and found to potentiate
NO-independent CPA- and ACh-evoked dilatations, although
less effectively than in ring preparations where the endo-
thelium was directly exposed to the same concentration of
H2O2. This reduction in potency is likely to reﬂect a concen-
tration gradient of H2O2 across the wall of the segments
because their intraluminal perfusate did not contain H2O2
and the RIA possesses 10 layers of smooth muscle cells
and is therefore relatively thick-walled.
3 It thus seems
likely that putative H2O2-dependent pro-oxidant effects of
AA and BH4 on endothelial function in vivo would be most
pronounced in the microcirculation because (i) the adventi-
tial–endothelial concentration gradient of H2O2 would be
smaller than in conduit arteries and (ii) gap junction-
dependent mechanisms can dominate over NO-mediated
vasodilatation in resistance arteries,
23 consistent with
Figure 2 Concentration-dependent potentiation of EDHF-type relaxations/dilatations to CPA and ACh in the presence of exogenous H2O2.( A) In tension myo-
graph experiments, buffer [H2O2] was unchanged at the conclusion of the experiments (bar graph, illustrated for ACh). (B) In perfusion experiments, intraluminal
and extraluminal [H2O2] at the conclusion of each experiment were similarly unchanged (bar graphs). ** and *** denote P , 0.01 and 0.001 for speciﬁc concen-
trations of CPA or ACh compared with control.
Table 2 Effects of adventitially applied H2O2 on EDHF-type
dilatations evoked by CPA and ACh
n pEC50 Dmax %
CPA
Control 5 4.79+0.04 88.0+2.3
H2O2 (100 mM) 5 5.09+0.05* 91.4+2.9
Ach
Control 5 6.30+0.08 78.2+4.7
H2O2 (100 mM) 5 6.75+0.09* 82.6+2.0
Potency (negative log EC50) and maximal dilatation (Dmax) expressed as
a percentage of the dilator response to SNP are given as mean+SEM.
*P, 0.01 compared with control.
A. Garry et al. 222evidence that the number of myoendothelial connections
per endothelial cell is highest in small arteries.
24
4.1 Mechanisms involved in the generation of H2O2
To gain insights into the pathways whereby AA and BH4 gen-
erate H2O2 in physiological buffer, experiments were con-
ducted to evaluate the contribution of the superoxide
anion (.O2
2), which has been implicated in the autoxidation
of BH4, but whose role in the oxidation of AA is controver-
sial.
14,15,25,26 In myograph studies with rings, SOD attenu-
ated the potentiating effects of BH4 on CPA-evoked
relaxations and associated formation of H2O2, whereas the
generation of H2O2 from AA and its potentiating effects on
relaxation were unaffected. Spin trap analysis has shown
that BH4 reacts with molecular oxygen at physiological
pH to generate .O2
2, which then drives a chain reaction
involving the reduction of molecular oxygen via an inter-
mediary BH4 radical that accelerates the rate of BH4 oxi-
dation by 5-fold.
15 Loss of this chain reaction is likely to
explain the ability of SOD to attenuate H2O2 formation and
relaxation in the present study, since SOD causes a marked
reduction the rate of BH4 autoxidation.
15 In contrast,
aqueous solutions of AA are stable at pH 7 unless trace
concentrations of Fe
3þ or Cu
2þ ions (normally present in
commercially available salts) are present as contaminants
that catalyze its oxidation.
25,27 We were thus unable to
detect formation of H2O2 from AA in deionized water and
found that the generation of H2O2 from AA in buffer was sub-




25,27 whereas formation of
H2O2 from BH4 was unaffected. Conversely, 1 mMF e
3þ or
Figure 3 Effects of SOD (1200 U/mL) on concentration–response curves for
CPAandgeneration ofH2O2from1 mMAA.(A)SODdidnotaffect thepotentiat-
ing effects of AA on relaxation or elevations in myograph [H2O2] at 30 and
60 min (insets). (B) Time course of the generation of H2O2 in oxygenated
buffer. (C) DTPA reduced the formation of H2O2 in well-oxygenated buffer
and no generation of H2O2 was evident in comparative experiments performed
in deionized water (dH2O). (D) SOD did not affect the generation ofH2O2 either
in well-oxygenated buffer or air-exposed buffer (open columns). ** and
*** denote P , 0.01 and 0.001 compared with the appropriate control.
Figure 4 Effects of SOD (1200 U/mL) on concentration–response curves for
CPA and generation of H2O2 from 200 mMB H 4.( A) SOD attenuated the poten-
tiating effects of BH4 on relaxation and the associated increase in myograph
[H2O2] after 30 but not 60 min (insets). (B) Time course of H2O2 generation in
oxygenated buffer. (C) DTPA did not affect the formation of H2O2 in oxyge-
nated buffer. (D) Inhibitory effects of SOD were much less evident in well-
oxygenated buffer than air-exposed buffer (open columns). *
, ** and ***
denote P , 0.05, 0.01, and 0.001 compared with control.
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2þ catalyzed the generation of H2O2 from 1 mM AA, with
Cu
2þ being by far the more active cation (see Supplementary
material online). Although metal-catalyzed oxidation of AA
has been suggested to involve the interaction of .O2
2 with
ascorbate ions and the ascorbyl radical, the effects of SOD
on the rate of AA oxidation were modest (less than 2-fold
decrease),
14 and it has also been proposed that metal-
catalyzed oxidation (e.g. of 6-hydroxydopamine and
1,2,4-benzenetriol) can proceed via a 2-electron mechanism
in which H2O2 is generated directly from molecular oxygen
(rather than .O2
2) and is therefore insensitive to SOD.
28,29
The impact of oxygenation on H2O2 accumulation was exam-
ined in experiments conducted with buffer exposed to air,
because isolated arterial preparations are conventionally
maintained in buffer gassed with O2 at levels well above
the physiological range. Such studies demonstrated a
50% reduction in H2O2 generated from AA after 30 min
compared with oxygenated buffer, whereas H2O2 formation
from BH4 was unaltered. Major differences in the role of
intermediary.O2
2 in the oxidation of AA and BH4 were never-
theless highlighted by observations that the generation of
H2O2 from BH4 in buffer exposed to air was suppressed by
SOD, whereas its formation from AA under the same con-
ditions was unaffected.
4.2 Role of gap junctions
Studies with connexin-mimetic peptides have conﬁrmed the
underlying electrotonic nature of NO- and
prostanoid-independent responses to CPA and ACh in rabbit
arteries, and shown that such peptides do not attenuate
direct NO-mediated relaxation or endothelial release of
endogenous NO in sandwich bioassay experiments.
3,7,8,30
As previously reported, CPA-evoked relaxations of the RIA
were attenuated by the peptide VCYDKSFPISHVR (
43Gap26;
100 mM), which possesses homology with the ﬁrst extracellu-
lar loop of Cx43, the dominant connexin expressed in the
media of the RIA and interrupts the spread of CPA-evoked
endothelial hyperpolarization through the vessel wall.
3,7,8
In the present study, the inhibitory effects of 100 mM
43Gap 26 and the potentiating effects of 100 mMH 2O2 on
CPA-evoked relaxation cancelled when both agents were
present simultaneously, with relaxation then being main-
tained at control levels. This may, at least in part, reﬂect
oxidation of the thiol group of the cysteine residue of
43Gap26 by H2O2, because dimerization via the formation
of an intermolecular cystine bridge was conﬁrmed by mass
spectrometry and there was 50% consumption of applied
H2O2 in the presence of equimolar peptide concentrations,
consistent with the reaction 2R-SHþH2O2!R-S-S-Rþ2
H2O. However, we also found that a truncated peptide
YDKSFPISHVR mimicked the effects of
43Gap26 when
applied at 300 mM, suggesting speciﬁc gap junction blockade
because oxidation/dimerization of this peptide was pre-
vented by deletion of the N-terminal valine and cysteine
residues. Furthermore, the peptide SRPTEK, which corre-
sponds to a highly conserved sequence in the second extra-
cellular loops of the principal endothelial connexins
expressed in the RIA (Cx37 and Cx40), as well as Cx43,
3
caused near-complete inhibition of ACh-evoked EDHF-type
relaxations, even when these were potentiated by H2O2.
This short peptide may therefore be considered a general,
redox-insensitive inhibitor of gap junction signalling
because (i) SRPTEK did not dimerize in the presence of
H2O2, (ii) assay revealed no consumption of buffer H2O2,
and (iii) the D-isoform (srptek) was biologically inactive,
suggesting that loss of relaxation driven by SRPTEK involves
a speciﬁc molecular recognition event at the cell surface.
We have previously shown that 100 mMB H 4 opposes the
ability of equimolar concentrations of
43Gap26 or the
related peptide
37,40Gap26 (VCYDQAFPISHIR, which targets
Cx37 and Cx40) to inhibit CPA-evoked EDHF-type relaxations
and smooth muscle hyperpolarization in the RIA.
7 At this
concentration, BH4 generates myograph H2O2 concen-
trations of 40 mM (data not shown) and could therefore
contribute to the normalization of EDHF-type responses
both via the potentiation of ER Ca
2þ mobilization and
Figure 5 Effects of connexin-mimetic peptides on control EDHF-type relax-
ations and their potentiation by exogenous H2O2.( A) Attenuation of
CPA-evoked relaxations by
43Gap 26 and its truncated form YDKSFPISHVR
were both reversed by 100 mMH 2O2.( B) SRPTEK almost abolished relaxations
to ACh, both in the presence and absence of 100 mMH 2O2, whereas srptek was
inactive. (C)
43Gap 26 but not SRPTEK reduced applied [H2O2] in oxygenated
buffer. ** and *** denote P , 0.01 and 0.001 compared with control.
A. Garry et al. 224peptide oxidation. However, at concentrations normally
found in plasma (50–100 mM), which are lower than those
employed in the present experiments, AA can also oppose





should also be noted that in non-vascular cells H2O2 has
been variously shown to enhance or inhibit intercellular
coupling via gap junctions constructed from Cx43, probably
by alternating the phosphorylation/oxidation status of resi-
dues present in the intracellular cytoplasmic tail of this con-
nexin subtype.
31–35 Indeed, the hyperphosphorylation of
Cx43 that follows administration of H2O2 or phorbol esters
(which generate .O2
2) can be prevented by a spectrum of
antioxidants, including AA, with preservation of channel
function.
36,37 Further studies are therefore necessary to
evaluate the effects of competing pro- and antioxidant
mechanisms on gap junctional communication in the endo-
thelial and smooth muscle layers of the vessel wall, and
how their contributions might vary under different exper-
imental conditions because AA and BH4 are both capable
of reducing H2O2 to H2O as well as generating H2O2.
14,15,38,39
4.3 Conclusions
Clinical studies have suggested that AA and BH4 can both
improve endothelial dysfunction in human conduit arteries
by increasing the bioavailability of NO, provided that
pharmacological doses are administered systemically.
9–12
The present ﬁndings raise the possibility that high concen-
trations of AA and BH4 might also reverse endothelial dys-
function by amplifying the EDHF-type responses that have
been postulated to compensate for loss of NO-dependent
dilatation. It should thus be noted that the concentration
of AA employed in the present in vitro studies (1 mM) is
lower than the venous concentrations (1.5–3.2 mM) associ-
ated with restoration of endothelial responsiveness to
ACh/methacholine in forearm plethysmographic studies in
patients with hypertension or peripheral arterial disease fol-
lowing intra-brachial arterial administration of AA.
10,11 As
noted above, such concentrations of circulating AA can
elevate interstitial ﬂuid [H2O2] to levels that potentiated
NO-independent dilatation when applied to the adventitia
of RIA segments. Corresponding measurements of interstitial
[H2O2] are not available for BH4, although the infusion rates
found necessary to prevent endothelial dysfunction follow-
ing ischaemia–perfusion injury in the human forearm lead
to total circulating biopterin concentrations of 100 mM
and appear to involve mechanisms distinct from the role
of BH4 as a co-factor for eNOS.
40 Further studies are there-
fore needed to assess the effects of extracellularly gener-
ated H2O2 on endothelial function in vivo. Because H2O2
production from .O2
2 is normally attenuated by NO through
an interaction that results in the formation of peroxynitrite,
it also remains to be determined if the reduction in NO bioa-
vailability that characterizes many vascular disease states
upregulates the EDHF phenomenon directly.
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Supplementary material is available at Cardiovascular
Research online.
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